Clinical trials
Phase 1/2 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 10 |
| Recruiting | 9 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| AC Immune SA | 1 |
| Actinogen Medical | 1 |
| Adeona Pharmaceuticals | 1 |
| Beni-Suef University | 1 |
| Biomind Labs Inc. | 1 |
| Chengdu University of Traditional Chinese Medicine | 1 |
| Friendi.fi Corporation | 1 |
| Fudan University | 1 |
| Hong Kong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 42 |
| Alzheimer Disease | 16 |
| Dementia | 7 |
| Anxiety Disorders | 2 |
| Neurodegenerative Diseases | 2 |
| Parkinson Disease | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Autism Spectrum Disorder | 1 |
| Autistic Disorder | 1 |
| Brain Diseases | 1 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.